Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 144
Filtrar
1.
Exp Cell Res ; 402(2): 112576, 2021 05 15.
Artigo em Inglês | MEDLINE | ID: mdl-33798592

RESUMO

The brain vasculature has several specific features, one of them being the blood-brain barrier (BBB), which supports and protects the brain by allowing for the passage of oxygen and nutrients, while at the same time preventing passage of pathogens and toxins. The BBB also prevents efficient delivery of drugs to the brain, e.g. for treatment of brain tumors. In the murine brain, perivascular fibroblasts were recently identified as a novel potential constituent of the BBB. Here we present the existence of human cells that could be the equivalent to the murine brain perivascular fibroblasts. Using RNA sequencing, we show a similar transcriptomic profile of cultured human brain cells and murine perivascular fibroblasts. These data open up a window for new hypotheses on cell types involved in human CNS diseases.


Assuntos
Encéfalo/ultraestrutura , Linhagem da Célula/genética , Sistema Nervoso Central/ultraestrutura , Fibroblastos/metabolismo , Animais , Transporte Biológico/genética , Barreira Hematoencefálica/ultraestrutura , Encéfalo/irrigação sanguínea , Encéfalo/metabolismo , Sistema Nervoso Central/irrigação sanguínea , Sistema Nervoso Central/metabolismo , Sistemas de Liberação de Medicamentos , Humanos , Camundongos
2.
Int J Mol Sci ; 21(4)2020 Feb 24.
Artigo em Inglês | MEDLINE | ID: mdl-32102323

RESUMO

Translational readthrough (TRT) of aquaporin-4 (AQP4) has remarkably expanded the importance of this new post-transcriptional mechanism, as well as the regulation potential of AQP4. The TRT isoform of AQP4, named AQP4ex, is central for both AQP4 polarization and water channel activity in the central nervous system (CNS). Here we evaluate the relevance of the TRT mechanism by analyzing whether AQP4ex is also expressed in peripheral tissues and whether the expression of AQP4ex is necessary for its polarized expression as it occurs in perivascular astrocyte processes. To this purpose, AQP4ex null mice were used, and analysis was performed by immunolocalization and immunoblot. The results demonstrate that AQP4ex is expressed in kidney, stomach, trachea and skeletal muscle with the same localization pattern as the canonical AQP4 isoforms. AQP4ex protein levels vary from 6% to about 13% of the total AQP4 protein levels in peripheral tissues. Immunogold electron microscopy experiments demonstrated the localization of AQP4ex at the astrocytic endfeet, and experiments conducted on AQP4ex null mice CNS confirmed that the expression of AQP4ex is necessary for anchoring of the perivascular AQP4. Without the readthrough isoform, AQP4 assemblies are mis-localized, being uniformly distributed on the astrocyte processes facing the neuropile. No alteration of AQP4 polarization was found in AQP4ex null kidney, stomach, trachea or skeletal muscle, suggesting that AQP4ex does not have a role for proper membrane localization of AQP4 in peripheral tissues. We conclude that a dual role for AQP4ex is limited to the CNS.


Assuntos
Aquaporina 4/genética , Astrócitos/metabolismo , Sistema Nervoso Central/metabolismo , Regulação da Expressão Gênica , Animais , Aquaporina 4/metabolismo , Astrócitos/ultraestrutura , Sistema Nervoso Central/ultraestrutura , Immunoblotting , Rim/metabolismo , Camundongos , Camundongos Knockout , Microscopia Imunoeletrônica , Músculo Esquelético/metabolismo , Isoformas de Proteínas/genética , Isoformas de Proteínas/metabolismo , Estômago/química , Traqueia/metabolismo , Proteína Tumoral 1 Controlada por Tradução
3.
Neurosci Lett ; 652: 56-63, 2017 Jun 23.
Artigo em Inglês | MEDLINE | ID: mdl-27989572

RESUMO

Injured neurons in the adult mammalian central nervous system (CNS) have a very limited capacity for axonal regeneration and neurite outgrowth. This inability to grow new axons or to regrow injured axons is due to the presence of molecules that inhibit axonal growth, and age related changes in the neuron's innate growth capabilities. Available levels of cAMP are thought to have an important role in linking both of these factors. Elevated levels of cAMP in the developing nervous system are important for the guidance and stability of growth cones. As the nervous system matures, cAMP levels decline and the growth promoting effects of cAMP diminish. It has frequently been demonstrated that increasing neuronal cAMP can enhance neurite growth and regeneration. Some methods used to increase cAMP include administration of cAMP agonists, conditioning lesions, or electrical stimulation. Furthermore, it has been proposed that multiple stages of cAMP induced growth exist, one directly caused by its downstream effector Protein Kinase A (PKA) and one caused by the eventual upregulation of gene transcription. Although the role cAMP in promoting axon growth is well accepted, the downstream pathways that mediate cAMP-mediated axonal growth are less clear. This is partly because various key studies that explored the link between PKA and axonal outgrowth relied on the PKA inhibitors KT5720 and H89. More recent studies have shown that both of these drugs are less specific than initially thought and can inhibit a number of other signalling molecules including the Exchange Protein Activated by cAMP (EPAC). Consequently, it has recently been shown that a number of intracellular signalling pathways previously attributed to PKA can now be attributed solely to activation of EPAC specific pathways, or the simultaneous co-activation of PKA and EPAC specific pathways. These new studies open the door to new potential treatments for repairing the injured spinal cord.


Assuntos
Sistema Nervoso Central/metabolismo , AMP Cíclico/metabolismo , Neuritos/fisiologia , Animais , Sistema Nervoso Central/lesões , Sistema Nervoso Central/ultraestrutura , Proteínas Quinases Dependentes de AMP Cíclico/metabolismo , Estimulação Elétrica , Humanos , Fatores de Crescimento Neural/metabolismo , Regeneração Nervosa , Traumatismos da Medula Espinal/metabolismo , Traumatismos da Medula Espinal/patologia , Traumatismos da Medula Espinal/terapia
4.
J Neuroimmunol ; 297: 98-102, 2016 08 15.
Artigo em Inglês | MEDLINE | ID: mdl-27397082

RESUMO

We aimed to identify new cell-membrane antigens implicated in opsoclonus-myoclonus with neuroblastoma. The sera of 3 out of 14 patients showed IgG electron-microscopy immunogold reactivity on SH-SY5Y neuroblastoma cells. Immunoprecipitation experiments using rat brain synaptosomes and SH-SY5Y cells led to the identification of: (1) thirty-one nuclear/cytoplasmic proteins (including antigens HuB, HuC); (2) seven neuronal membrane proteins, including the Shaw-potassium channel Kv3.3 (KCNC3), whose genetic disruption in mice causes ataxia and generalized muscle twitching. Although cell-based assays did not demonstrate direct antigenicity, our findings point to Shaw-related subfamily of the potassium voltage-gated channels complexed proteins as hypothetical antigenic targets.


Assuntos
Neoplasias Encefálicas , Sistema Nervoso Central/metabolismo , Neuroblastoma , Síndrome de Opsoclonia-Mioclonia , Animais , Neoplasias Encefálicas/complicações , Neoplasias Encefálicas/imunologia , Neoplasias Encefálicas/patologia , Moléculas de Adesão Celular Neuronais/metabolismo , Linhagem Celular Tumoral , Sistema Nervoso Central/ultraestrutura , Criança , Bases de Dados Factuais/estatística & dados numéricos , Encefalite/complicações , Encefalite/imunologia , Feminino , Células HEK293 , Humanos , Masculino , Proteínas de Membrana/metabolismo , Proteínas do Tecido Nervoso/metabolismo , Proteínas do Tecido Nervoso/ultraestrutura , Neuroblastoma/complicações , Neuroblastoma/imunologia , Neuroblastoma/patologia , Proteínas Nucleares/metabolismo , Proteínas Nucleares/ultraestrutura , Síndrome de Opsoclonia-Mioclonia/complicações , Síndrome de Opsoclonia-Mioclonia/imunologia , Síndrome de Opsoclonia-Mioclonia/patologia , Ratos , Ratos Wistar , Canais de Potássio Shaw/imunologia , Canais de Potássio Shaw/metabolismo , Canais de Potássio Shaw/ultraestrutura , Sinaptossomos/metabolismo , Sinaptossomos/ultraestrutura , Timoma/complicações
5.
J Neurochem ; 135(3): 492-507, 2015 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-26195140

RESUMO

Multiple C2 domains transmembrane protein 1 (MCTP1) contains two transmembrane regions and three C2 domains of high Ca(2+)-binding affinity. Single-nucleotide polymorphism (SNP) of human MCTP1 gene is reportedly associated with bipolar disorder, but expression and function of MCTP1 in the CNS is still largely unknown. We cloned rat MCTP1 isoforms, and studied expression of MCTP1 transcript and protein in the CNS. Subcellular distribution and functional roles of MCTP1 were investigated in cultured primary neurons or PC12 cells by over-expression, cell imaging, and flow cytometry. MCTP1 immunostaining was seen in both CNS neuronal cell bodies and processes, especially in the hippocampus, dentate gyrus, medial habenular nucleus, amygdala, and selected cerebral and cerebellar cortical areas/layers. Under an electron microscope, MCTP1 immunoreactivity was observed on vesicles in neuronal cell bodies and pre-synaptic axon terminals. In cultured primary neurons and PC12 cells MCTP1 was detected on selected populations of secretory vesicles and endosomes. MCTP1 over-expression significantly inhibited neuronal transferrin endocytosis, secretory vesicle retrieval, cell migration, and oxidative stress from glutamate toxicity. Thus MCTP1 might be involved in regulating endocytic recycling of specific CNS neurons and synapses. MCTP1 abnormality might cause altered synaptic vesicle recycling, and thereby lead to vulnerability to neuropsychiatric diseases.


Assuntos
Sistema Nervoso Central/metabolismo , Proteínas de Membrana/biossíntese , Neurônios/metabolismo , Estresse Oxidativo/fisiologia , Vesículas Sinápticas/fisiologia , Animais , Células Cultivadas , Sistema Nervoso Central/ultraestrutura , Feminino , Regulação da Expressão Gênica , Humanos , Masculino , Neurônios/ultraestrutura , Células PC12 , Gravidez , Coelhos , Ratos , Ratos Wistar
6.
Pesqui. vet. bras ; 35(7): 685-690, jul. 2015. graf
Artigo em Inglês | LILACS | ID: lil-766203

RESUMO

Although ultrastructural characteristics of mature neuroglia in the central nervous system (CNS) are very well described in mammals, much less is known in reptiles, especially serpents. In this context, two specimens of Bothrops jararaca were euthanized for morphological analysis of CNS glial cells. Samples from telencephalon, mesencephalon and spinal cord were collected and processed for light and transmission electron microscopy investigation. Astrocytes, oligodendrocytes, microglial cells and ependymal cells, as well as myelin sheaths, presented similar ultrastructural features to those already observed in mammals and tended to maintain their general aspect all over the distinct CNS regions observed. Morphological similarities between reptilian and mammalian glia are probably linked to their evolutionary conservation throughout vertebrate phylogeny...


Muito embora as características ultraestruturais da neuróglia madura do sistema nervoso central (SNC) sejam bem descritas em mamíferos, muito pouco é conhecido em répteis, especialmente em serpentes. Neste contexto, dois espécimes de Bothrops jararaca foram eutanasiados para análise morfológica das células gliais presentes no SNC. Amostras de telencéfalo, mesencéfalo e medula espinhal foram coletadas e processadas para investigação por microscopia de luz e eletrônica de transmissão. Astrócitos, oligodendócitos, células microgliais e ependimárias, bem como bainhas de mielina, apresentaram características ultraestruturais similares àquelas já observadas em mamíferos e tenderam a manter seu aspecto geral pelas diferentes regiões observadas no SNC. Similaridades morfológicas entre as células gliais de mamíferos e de répteis estão provavelmente ligadas a sua conservação evolutiva ao longo da filogenia dos vertebrados...


Assuntos
Animais , Bothrops/anatomia & histologia , Neuroglia/ultraestrutura , Sistema Nervoso Central/ultraestrutura , Forma do Núcleo Celular , Serpentes/anatomia & histologia
7.
Biomed Res Int ; 2015: 645603, 2015.
Artigo em Inglês | MEDLINE | ID: mdl-25879034

RESUMO

The effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on central nervous system consists of changing expression of estrogen receptors, whereas the result of chronic inflammatory reaction caused by dioxin is occurrence of destructive changes in various organs connected with disturbed metabolism of connective tissue and damage of cells. The aim of the study was to determine the effect of dioxins on function, ultrastructure, and cytological and histological structure of hippocampus, particularly on expression of estrogen receptors in central nervous system as well as to define protective influence of tocopherol (TCP) and acetylsalicylic acid (ASA) on the decrease in activity of proinflammatory effects in central nervous system. It was shown that TCDD contributes to destructive and inflammatory changes along with demyelization of myelin sheaths and atrophy of estrogen receptors in hippocampus. Dioxin contributes to atrophy of estrogen receptors in hippocampus, in which also destructive and inflammatory changes were found along with demyelination of myelin sheaths. Histopathological and ultrastructural image of hippocampus areas in rats, in which both TCP and ASA were used, is characterized by poorly expressed degenerative changes and smaller inflammatory reactivity. Using both TCP and ASA has a protective effect on functions of central nervous system.


Assuntos
Aspirina/administração & dosagem , Sistema Nervoso Central/efeitos dos fármacos , Hipocampo/efeitos dos fármacos , Tocoferóis/administração & dosagem , Animais , Aspirina/metabolismo , Sistema Nervoso Central/metabolismo , Sistema Nervoso Central/fisiopatologia , Sistema Nervoso Central/ultraestrutura , Hipocampo/metabolismo , Hipocampo/fisiopatologia , Hipocampo/ultraestrutura , Fármacos Neuroprotetores/administração & dosagem , Dibenzodioxinas Policloradas/toxicidade , Ratos , Receptores de Estrogênio/metabolismo , Tocoferóis/metabolismo
8.
J Neurosci ; 34(24): 8175-85, 2014 Jun 11.
Artigo em Inglês | MEDLINE | ID: mdl-24920622

RESUMO

Current multiple sclerosis (MS) therapies only partially prevent chronically worsening neurological deficits, which are largely attributable to progressive loss of CNS axons. Prior studies of experimental autoimmune encephalomyelitis (EAE) induced in C57BL/6 mice by immunization with myelin oligodendrocyte glycoprotein peptide 35-55 (MOG peptide), a model of MS, documented continued axon loss for months after acute CNS inflammatory infiltrates had subsided, and massive astroglial induction of CCL2 (MCP-1), a chemokine for CCR2(+) monocytes. We now report that conditional deletion of astroglial CCL2 significantly decreases CNS accumulation of classically activated (M1) monocyte-derived macrophages and microglial expression of M1 markers during the initial CNS inflammatory phase of MOG peptide EAE, reduces the acute and long-term severity of clinical deficits and slows the progression of spinal cord axon loss. In addition, lack of astroglial-derived CCL2 results in increased accumulation of Th17 cells within the CNS in these mice, but also in greater confinement of CD4(+) lymphocytes to CNS perivascular spaces. These findings suggest that therapies designed to inhibit astroglial CCL2-driven trafficking of monocyte-derived macrophages to the CNS during acute MS exacerbations have the potential to significantly reduce CNS axon loss and slow progression of neurological deficits.


Assuntos
Astrócitos/metabolismo , Axônios/patologia , Sistema Nervoso Central/patologia , Quimiocina CCL2/metabolismo , Encefalomielite Autoimune Experimental/patologia , Macrófagos/metabolismo , Análise de Variância , Animais , Axônios/ultraestrutura , Proteínas de Bactérias/genética , Sistema Nervoso Central/ultraestrutura , Quimiocina CCL2/genética , Citometria de Fluxo , Proteína Glial Fibrilar Ácida/genética , Proteína Glial Fibrilar Ácida/metabolismo , Proteínas Luminescentes/genética , Macrófagos/imunologia , Macrófagos/ultraestrutura , Camundongos , Camundongos Endogâmicos C57BL , Camundongos Transgênicos , Microscopia Eletrônica de Transmissão , Glicoproteína Mielina-Oligodendrócito/toxicidade , Fragmentos de Peptídeos/toxicidade , Proteínas/genética
9.
Curr Pharm Des ; 19(33): 5974-96, 2013.
Artigo em Inglês | MEDLINE | ID: mdl-23448451

RESUMO

Fabry disease (FD) is a rare X-linked lysosomal storage disorder caused by a deficiency of the enzyme α-galactosidase A. FD causes glycolipids, such as globotriaosylceramide (Gb3), to accumulate in the vascular endothelium of several organs (Fig. 2), including the skin, kidneys, nervous system, and heart, thereby triggering inflammation and fibrosis. These processes generally result in organ dysfunction, which is usually the first clinical evidence of FD. Patients with classic FD have various symptoms, eg, acroparesthesias, hypohidrosis, angiokeratomas, corneal opacities, cerebrovascular lesions, cardiac disorders, andrenal dysfunction.However, evolving knowledge about the natural course of disease suggests that it is more appropriate to describe FD as a disease with a wide spectrum of heterogeneously progressive clinical phenotypes. Indeed, most female heterozygotes develop symptoms due to yet undetermined mechanisms and a high percentage of females develops vital organ involvement including the kidneys, heart and/or brain about a decade later than males. Renal failure is a serious complication of this disease. Fabry nephropathy lesions are present and progress in childhood while the disease commonly remains silent by routine clinical measures. Early and timely diagnosis of Fabry nephropathy is crucial since late initiation of enzyme replacement therapy may not halt progressive renal dysfunction. This may be challenging due to difficulties in diagnosis of Fabry disease in children and absence of a sensitive non-invasive biomarker of early Fabry nephropathy. Accurate measurement of glomerular filtration rate and regular assessment for proteinuria and microalbuminuria are useful, though not sensitive enough to detect early lesions in the kidney. The principal clinical manifestations in Fabry disease consist of artery associated complications (such as cerebral disease and nephropathy), but the pathophysiology of this specific vasculopathy is unclear. Several studies indicate that the specific vascular lesions that are present in Fabry disease occur as a result of vascular dysfunction with major components being endothelial dysfunction, alterations in cerebral perfusion and a pro-thrombotic phenotype. Fabry cardiac involvement has several clinical manifestations (Table 10): concentric left ventricular hypertrophy without left ventricular dilation and severe loss of left ventricular systolic function, mitral and aortic valvulopathy, disorders of the atrioventricular conduction or repolarization, and compromised diastolic function. The neurological manifestations of Fabry disease include both peripheral nervous system and CNS involvement, with globotriaosylceramide accumulation found in Schwann cells and dorsal root ganglia together with deposits in CNS neurones. The main involvement of the CNS is attributable to cerebrovasculopathy, with an increased incidence of stroke. The abnormal neuronal accumulation of glycosphingolipid appears to have little clinical effect on the natural history of Fabry disease, with the possible exception of some reported mild cognitive abnormalities. The pathogenesis of Fabry vasculopathy remains poorly understood, but probably relates, in part, to abnormal functional control of the vessels, secondary to endothelial dysfunction as a consequence of α-galactosidase A deficiency. The diagnosis of Fabry disease is made in hemizygous males after the detection of the presence of angiokeratomas (Fig. 19 A, B), irregularities in sweating, edema, scant body hair, painful sensations, and of cardiovascular, intestinal, renal, ophthalmologic, phlebologic, and respiratory involvement. A deficiency of alpha-gal A in serum, leukocytes, tears, tissue specimens, or cultured skin fibroblasts further supports the diagnosis in male patients. Since heterozygous women show angiokeratomas in only about 30% of cases and may have alpha-gal A levels within normal range, genetic analysis is recommended. The resultant storage of undegraded glycolipids leads to the progressive development of potentially life-threatening manifestations affecting multiple organ systems in the body. The Mainz Severity Score Index (MSSI) (Table 12), a scoring system for patients with Fabry disease has been proven to be representative in patients with 'classic' Fabry disease and may be useful for monitoring clinical improvement in patients receiving enzyme replacement therapy. The MSSI of patients with AFD was significantly higher than that of patients with other severe debilitating diseases.


Assuntos
Sistema Nervoso Central/patologia , Doença de Fabry/complicações , Rim/patologia , Pele/patologia , Fatores Etários , Sistema Nervoso Central/metabolismo , Sistema Nervoso Central/ultraestrutura , Terapia de Reposição de Enzimas , Doença de Fabry/genética , Doença de Fabry/metabolismo , Doença de Fabry/patologia , Feminino , Humanos , Rim/metabolismo , Rim/ultraestrutura , Masculino , Qualidade de Vida , Índice de Gravidade de Doença , Caracteres Sexuais , Pele/metabolismo
10.
Curr Med Chem ; 19(9): 1277-81, 2012.
Artigo em Inglês | MEDLINE | ID: mdl-22304706

RESUMO

Glutamate carboxypeptidase II, also known as prostate specific membrane antigen or folate hydrolase I, is a type II transmembrane 750 amino acid membrane-bound glycoprotein, with a molecular weight in the human form of approximately 100 kDa and a demonstrated metallopeptidase activity. At the synaptic level it hydrolyzes N-acetylaspartylglutamate to N-acetyl-aspartate and glutamate. Its localization in the animal and human nervous system has only recently been clearly established, since many of the older studies gave conflicting results, likely due to the use of poorly characterized antibodies lacking epitope mapping and proper controls (i.e. immunohistochemistry complemented by western blot analysis and enzyme activity determination). In this chapter, we will review the available literature describing the animal and human distribution of glutamate carboxypeptidase in the central and peripheral nervous system.


Assuntos
Sistema Nervoso Central/enzimologia , Glutamato Carboxipeptidase II/análise , Sistema Nervoso Periférico/enzimologia , Animais , Sistema Nervoso Central/metabolismo , Sistema Nervoso Central/ultraestrutura , Dipeptídeos/metabolismo , Glutamato Carboxipeptidase II/metabolismo , Humanos , Sistema Nervoso Periférico/metabolismo , Sistema Nervoso Periférico/ultraestrutura
11.
Mol Cell Neurosci ; 49(1): 13-22, 2012 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-21903164

RESUMO

Children with the neurofibromatosis-1 (NF1) cancer predisposition syndrome exhibit numerous clinical problems that reflect defective central nervous system (CNS) neuronal function, including learning disabilities, attention deficit disorder, and seizures. These clinical features result from reduced NF1 protein (neurofibromin) expression in NF1+/- (NF1 heterozygosity) brain neurons. Previous studies have shown that mouse CNS neurons are sensitive to the effects of reduced Nf1 expression and exhibit shorter neurite lengths, smaller growth cone areas, and attenuated survival, reflecting attenuated neurofibromin cAMP regulation. In striking contrast, Nf1+/- peripheral nervous system (PNS) neurons are nearly indistinguishable from their wild-type counterparts, and complete neurofibromin loss leads to increased neurite lengths and survival in a RAS/Akt-dependent fashion. To gain insights into the differential responses of CNS and PNS neurons to reduced neurofibromin function, we designed a series of experiments to define the molecular mechanism(s) underlying the unique CNS neuronal sensitivity to Nf1 heterozygosity. First, Nf1 heterozygosity decreases cAMP levels in CNS, but not in PNS, neurons. Second, CNS neurons exhibit Nf1 gene-dependent increases in RAS pathway signaling, but no further decreases in cAMP levels were observed in Nf1-/- CNS neurons relative to their Nf1+/- counterparts. Third, neurofibromin regulates CNS neurite length and growth cone areas in a cAMP/PKA/Rho/ROCK-dependent manner in vitro and in vivo. Collectively, these findings establish cAMP/PKA/Rho/ROCK signaling as the responsible axis underlying abnormal Nf1+/- CNS neuronal morphology with important implications for future preclinical and clinical studies aimed at improving cognitive and behavioral deficits in mice and children with reduced brain neuronal NF1 gene expression.


Assuntos
Sistema Nervoso Central/ultraestrutura , AMP Cíclico/metabolismo , Heterozigoto , Neurofibromina 1/genética , Neurônios/ultraestrutura , Transdução de Sinais/fisiologia , Animais , Células Cultivadas , Sistema Nervoso Central/metabolismo , Proteínas Quinases Dependentes de AMP Cíclico/metabolismo , Genes da Neurofibromatose 1 , Cones de Crescimento/ultraestrutura , Camundongos , Camundongos Endogâmicos C57BL , Camundongos Knockout , Neuritos/metabolismo , Neuritos/ultraestrutura , Neurofibromatose 1/genética , Neurofibromatose 1/metabolismo , Neurofibromina 1/metabolismo , Neurônios/citologia , Neurônios/metabolismo , Quinases Associadas a rho/metabolismo
12.
Proc Natl Acad Sci U S A ; 108(32): E440-9, 2011 Aug 09.
Artigo em Inglês | MEDLINE | ID: mdl-21788491

RESUMO

Astrocytes regulate synaptic connectivity in the CNS through secreted signals. Here we identified two astrocyte-secreted proteins, hevin and SPARC, as regulators of excitatory synaptogenesis in vitro and in vivo. Hevin induces the formation of synapses between cultured rat retinal ganglion cells. SPARC is not synaptogenic, but specifically antagonizes synaptogenic function of hevin. Hevin and SPARC are expressed by astrocytes in the superior colliculus, the synaptic target of retinal ganglion cells, concurrent with the excitatory synaptogenesis. Hevin-null mice had fewer excitatory synapses; conversely, SPARC-null mice had increased synaptic connections in the superior colliculus. Furthermore, we found that hevin is required for the structural maturation of the retinocollicular synapses. These results identify hevin as a positive and SPARC as a negative regulator of synapse formation and signify that, through regulation of relative levels of hevin and SPARC, astrocytes might control the formation, maturation, and plasticity of synapses in vivo.


Assuntos
Astrócitos/metabolismo , Proteínas de Ligação ao Cálcio/metabolismo , Sistema Nervoso Central/metabolismo , Proteínas da Matriz Extracelular/metabolismo , Neurogênese , Osteonectina/metabolismo , Sinapses/metabolismo , Animais , Astrócitos/citologia , Astrócitos/efeitos dos fármacos , Astrócitos/ultraestrutura , Proteínas de Ligação ao Cálcio/antagonistas & inibidores , Proteínas de Ligação ao Cálcio/química , Proteínas de Ligação ao Cálcio/deficiência , Sistema Nervoso Central/citologia , Sistema Nervoso Central/ultraestrutura , Meios de Cultivo Condicionados/farmacologia , Proteínas da Matriz Extracelular/antagonistas & inibidores , Proteínas da Matriz Extracelular/química , Proteínas da Matriz Extracelular/deficiência , Células HEK293 , Humanos , Camundongos , Neurogênese/efeitos dos fármacos , Osteonectina/química , Osteonectina/deficiência , Estrutura Terciária de Proteína , Ratos , Ratos Sprague-Dawley , Células Ganglionares da Retina/citologia , Células Ganglionares da Retina/efeitos dos fármacos , Células Ganglionares da Retina/metabolismo , Células Ganglionares da Retina/ultraestrutura , Colículos Superiores/citologia , Colículos Superiores/efeitos dos fármacos , Colículos Superiores/metabolismo , Colículos Superiores/ultraestrutura , Sinapses/efeitos dos fármacos , Sinapses/ultraestrutura
13.
Rev. colomb. biotecnol ; 13(1): 42-51, jul. 2011. graf, ilus, tab
Artigo em Espanhol | LILACS | ID: lil-600572

RESUMO

Los modelos experimentales en rata han sido de gran utilidad en las evaluaciones terapéuticas o de reemplazo de células en enfermedades neurodegenerativas. Se ha comprobado que las células de la médula ósea (CMO) de ratas pueden diferenciarse en células que no forman parte de sus linajes normales. Hay evidencias de estos procesos de trans-diferenciación, pero aún no se conocen los mecanismos moleculares que activan estos procesos. El propósito de nuestro trabajo fue estudiar el polimorfismo genético del ADN de los tipos celulares que conforman las CMO y las células del sistema nervioso central (SNC), estríatales y de la corteza de ratas mediante la técnica de RAPD. Las CMO, las células mononucleares (CMMO), las células estromales (CEMO) y las del SNC fueron obtenidas de ratas, y su ADN genómico fue purificado y amplificado mediante la técnica de RAPD, utilizando 15 cebadores al azar. Se construyó un dendograma de las bandas de amplificación generadas utilizando el método de UPGMA. Las células estudiadas según el análisis del RAPD quedaron en 2 grupos bien definidos, pudiéndose diferenciar las CEMO del resto de las células estudiadas. Los cebadores OPA-6, 7 y 12, mostraron el polimorfismo genético de los linajes de células estudiadas. Mediante la técnica de RAPD se demostró la variabilidad genética entre las CEMO y las CMMO, células estriadas y de corteza que mostraron una homogeneidad genética, proponiéndose marcadores específicos de RAPD para cada grupo de células. Este es el primer estudio del polimorfismo genético de las CMO y del SNC de ratas.


Experimental models have been of grate usefulness in the therapeutic or replacement cells in neurodegenerative diseases. It has been demonstrated that bone marrow cells (BMC), can be difefferentiated in cells that do not form part of their normal lineage. There is evidence of these trans-differentiation processes in these cells, but nevertheless, molecular mechanisms that activate these differentiation process still not known. The purpose of our work was to study the genetic polymorphism of those cellular types; that conform the rat bone marrow cells (BMC) as well as those of the central nervous system (CNS), striatum cells and cortex ones, trough RAPD technique. BM, mononuclear cells (BMMC), estromal cells (BMSC) and the CNS cells were obtained from rats and genomic ADN was purified and amplified through RAPD technique, using 15 random primers. A dendogram was constructed according to UPGMA method of the amplifying RAPD bands. Studied cells as- according to the RAPD analysis- were grouped into 2 well- defined groups, as CEMO coud be differentiated from the rest of studied cells. OPA-6, 7 and 12 primers showed the genetic polymorphism of the studied lineages cells. Also will be proposed specific RAPD genetic markers. Through RAPD technique permitted the genetic variability was demonstrated betwen BMEC and BMMC of striated cells and of cortex, which demonstratd a genetic homogeneity through RAPD technique so specific genetic markers of RAPD were thus propose for each group of cells. These constitute the first study on genetic polymorphism of BMC and CNS.


Assuntos
Medula Óssea/anormalidades , Medula Óssea/crescimento & desenvolvimento , Medula Óssea/imunologia , Medula Óssea/ultraestrutura , Polimorfismo Genético/fisiologia , Polimorfismo Genético/genética , Técnica de Amplificação ao Acaso de DNA Polimórfico , Sistema Nervoso Central/anormalidades , Sistema Nervoso Central/lesões , Sistema Nervoso Central/metabolismo , Sistema Nervoso Central/microbiologia , Sistema Nervoso Central/ultraestrutura
14.
Hear Res ; 277(1-2): 44-53, 2011 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-21447373

RESUMO

The transition between the central (CNS) and peripheral nervous system (PNS) in cranial and spinal nerve roots, referred to here as the CNS-PNS border, is of relevance to nerve root disorders and factors that affect peripheral-central regeneration. Here, this border is described in the cat cochlear nerve using light microscopical sections, and scanning electron microscopy of the CNS-PNS interfaces exposed by fracture of the nerve either prior to or following critical point drying. The CNS-PNS border represents an abrupt change in type of myelin, supporting elements, and vascularization. Because central myelin is formed by oligodendrocytes and peripheral myelin by Schwann cells, the myelinated fibers are as a rule equipped with a node of Ranvier at the border passage. The border is shallower and smoother in cat cochlear nerve than expected from other nerves, and the borderline nodes are largely in register. The loose endoneurial connective tissue of the PNS compartment is closed at the border by a compact glial membrane, the mantle zone, of the CNS compartment. The mantle zone is penetrated by the nerve fibers, but is otherwise composed of astrocytes and their interwoven processes like the external limiting membrane of the brain surface with which it is continuous. The distal surface of the mantle zone is covered by a fenestrated basal lamina. Only occasional vessels traverse the border. From an anatomical point of view, the border might be expected to be a weak point along the cochlear nerve and thus vulnerable to trauma. In mature animals, the CNS-PNS border presents a barrier to regrowth of regenerating nerve fibers and to invasion of the CNS by Schwann cells. An understanding of this region in the cochlear nerve is therefore relevant to head injuries that lead to hearing loss, to surgery on acoustic Schwannomas, and to the possibility of cochlear nerve regeneration.


Assuntos
Sistema Nervoso Central/ultraestrutura , Nervo Coclear/ultraestrutura , Microscopia Eletrônica de Varredura , Sistema Nervoso Periférico/ultraestrutura , Animais , Astrócitos/ultraestrutura , Gatos , Sistema Nervoso Central/citologia , Nervo Coclear/citologia , Dissecação , Feminino , Técnicas de Preparação Histocitológica , Masculino , Fibras Nervosas/ultraestrutura , Neuroglia/ultraestrutura , Sistema Nervoso Periférico/citologia , Células de Schwann/ultraestrutura , Raízes Nervosas Espinhais/ultraestrutura
15.
J Nanobiotechnology ; 9: 5, 2011 Feb 18.
Artigo em Inglês | MEDLINE | ID: mdl-21332995

RESUMO

BACKGROUND: Nanoparticles (NPs) are widely studied for biomedical applications. Understanding interactions between NPs and biomolecules or cells has yet to be achieved. Here we present a novel in vivo method to study interactions between NPs and the nervous system of the discoid or false dead-head roach, Blaberus discoidalis. The aims of this study were to present a new and effective method to observe NPs in vivo that opens the door to new methods of study to observe the interactions between NPs and biological systems and to present an inexpensive and easy-to-handle biological system. RESULTS: Negatively charged gold nanoparticles (nAuNPs) of 50 nm in diameter were injected into the central nervous system (CNS) of the insect. By using such a cost effective method, we were able to characterize nAuNPs and to analyze their interactions with a biological system. It showed that the charged particles affected the insect's locomotion. The nAuNPs affected the insect's behavior but had no major impacts on the life expectancy of the cockroach after two months of observation. This was apparently due to the encapsulation of nAuNPs inside the insect's brain. Based on cockroach's daily activity, we believed that the encapsulation occurred in the first 17 days. CONCLUSIONS: The method proposed here is an inexpensive and reliable way of observing the response of biological systems to nanoparticles in-vivo. It opens new windows to further understand how nanoparticles affect neural communication by monitoring insect activity and locomotion.


Assuntos
Sistema Nervoso Central/efeitos dos fármacos , Ouro/administração & dosagem , Nanopartículas Metálicas/administração & dosagem , Animais , Sistema Nervoso Central/ultraestrutura , Baratas , Ouro/economia , Locomoção/efeitos dos fármacos , Masculino , Nanopartículas Metálicas/economia , Nanopartículas Metálicas/ultraestrutura
16.
Pesqui. vet. bras ; 30(8): 646-650, ago. 2010.
Artigo em Português | LILACS | ID: lil-559898

RESUMO

A infecção por herpesvírus bovino (BoHV) é uma das principais causas de doença neurológica em bovinos na região Centro-Oeste do Brasil. O uso de técnicas moleculares de diagnóstico representa uma contribuição importante para o estudo dessa doença. Este trabalho descreve o uso de uma técnica específica de PCR multiplex para identificar BoHV-5 e BoHV-1 em 76 amostras de encéfalo de bovinos fixadas em formol e incluídas em parafina. Com base nas alterações histológicas, as amostras foram separadas em 2 grupos: o Grupo 1 era composto de 40 amostras de bovinos com meningoencefalite necrosante característica da infecção por BoHV; no Grupo 2 estavam 36 amostras de casos com encefalite não-supurativa inespecífica. Identificação de BoHV-5 foi constatada em 40 por cento das amostras do grupo 1 e em 33 por cento das amostras do grupo 2. Não houve amplificação de DNA de BoHV-1 em nenhuma amostra.


Bovine herpesvirus (BoHV) is an important cause of neurological disease in cattle in the Midwest Brazil. The application of molecular diagnostic techniques represents an important contribution for the study of BoHV. This paper describes the detection of BoHV-5 and BoHV-1 by a specific multiplex PCR assay in 76 paraffin-embedded samples from central nervous system (CNS) of cattle with neurological disorders. The samples were divided into 2 groups according to the histological features: Group 1 was composed of 40 cases of necrotizing meningoencephalitis (characteristic of BoHV infection), and Group 2 was composed of 36 cases of nonspecific nonsuppurative meningoencephalitis. Positive results for BoHV-5 accounted for 40 percent of the samples in the group 1 and 33 percent in the group 2. No detection of BoHV-1 was recorded.


Assuntos
Animais , Bovinos , DNA Viral/análise , Herpesvirus Bovino 1/isolamento & purificação , Meningoencefalite/diagnóstico , Meningoencefalite/mortalidade , Meningoencefalite/veterinária , Meningoencefalite/virologia , Sistema Nervoso Central/ultraestrutura , Doenças Transmissíveis , Encefalopatia Espongiforme Bovina , Doenças Neurodegenerativas
17.
J Neurosci ; 30(6): 2257-67, 2010 Feb 10.
Artigo em Inglês | MEDLINE | ID: mdl-20147552

RESUMO

The Vav proteins are guanine exchange factors (GEFs) that trigger the activation of the Rho GTPases in general and the Rac family in particular. While the role of the mammalian vav genes has been extensively studied in the hematopoietic system and the immune response, there is little information regarding the role of vav outside of these systems. Here, we report that the single Drosophila vav homolog is ubiquitously expressed during development, although it is enriched along the embryonic ventral midline and in the larval eye discs and brain. We have analyzed the role that vav plays during development by generating Drosophila null mutant alleles. Our results indicate that vav is required during embryogenesis to prevent longitudinal axons from crossing the midline. Later on, during larval development, vav is required within the axons to regulate photoreceptor axon targeting to the optic lobe. Finally, we demonstrate that adult vav mutant escapers, which exhibit coordination problems, display axon growth defects in the ellipsoid body, a brain area associated with locomotion control. In addition, we show that vav interacts with other GEFs known to act downstream of guidance receptors. Thus, we propose that vav acts in coordination with other GEFs to regulate axon growth and guidance during development by linking guidance signals to the cytoskeleton via the modulation of Rac activity.


Assuntos
Axônios/fisiologia , Drosophila/ultraestrutura , Proteínas Proto-Oncogênicas c-vav/fisiologia , Animais , Padronização Corporal , Diferenciação Celular , Movimento Celular , Sistema Nervoso Central/embriologia , Sistema Nervoso Central/crescimento & desenvolvimento , Sistema Nervoso Central/metabolismo , Sistema Nervoso Central/ultraestrutura , Drosophila/embriologia , Drosophila/crescimento & desenvolvimento , Larva/crescimento & desenvolvimento , Larva/metabolismo , Larva/ultraestrutura , Mutação , Neuroglia/citologia , Neuroglia/metabolismo , Células Fotorreceptoras de Invertebrados/metabolismo , Células Fotorreceptoras de Invertebrados/ultraestrutura , Proteínas Proto-Oncogênicas c-vav/biossíntese , Proteínas Proto-Oncogênicas c-vav/genética
18.
Neuroscience ; 166(1): 73-83, 2010 Mar 10.
Artigo em Inglês | MEDLINE | ID: mdl-20004709

RESUMO

A polyclonal antibody (C4), raised against the head domain of chicken myosin Va, reacted strongly towards a 65 kDa polypeptide (p65) on Western blots of extracts from squid optic lobes but did not recognize the heavy chain of squid myosin V. This peptide was not recognized by other myosin Va antibodies, nor by an antibody specific for squid myosin V. In an attempt to identify it, p65 was purified from optic lobes of Loligo plei by cationic exchange and reverse phase chromatography. Several peptide sequences were obtained by mass spectroscopy from p65 cut from sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) gels. BLAST analysis and partial matching with expressed sequence tags (ESTs) from a Loligo pealei data bank indicated that p65 contains consensus signatures for the heterogeneous nuclear ribonucleoprotein (hnRNP) A/B family of RNA-binding proteins. Centrifugation of post mitochondrial extracts from optic lobes on sucrose gradients after treatment with RNase gave biochemical evidence that p65 associates with cytoplasmic RNP complexes in an RNA-dependent manner. Immunohistochemistry and immunofluorescence studies using the C4 antibody showed partial co-labeling with an antibody against squid synaptotagmin in bands within the outer plexiform layer of the optic lobes and at the presynaptic zone of the stellate ganglion. Also, punctate labeling by the C4 antibody was observed within isolated optic lobe synaptosomes. The data indicate that p65 is a novel RNA-binding protein located to the presynaptic terminal within squid neurons and may have a role in synaptic localization of RNA and its translation or processing.


Assuntos
Sistema Nervoso Central/metabolismo , Ribonucleoproteínas Nucleares Heterogêneas/metabolismo , Loligo/metabolismo , Proteínas do Tecido Nervoso/metabolismo , Terminações Pré-Sinápticas/metabolismo , Proteínas de Ligação a RNA/metabolismo , Animais , Sistema Nervoso Central/ultraestrutura , Gânglios dos Invertebrados/metabolismo , Gânglios dos Invertebrados/ultraestrutura , Ribonucleoproteínas Nucleares Heterogêneas/química , Ribonucleoproteínas Nucleares Heterogêneas/isolamento & purificação , Loligo/ultraestrutura , Peso Molecular , Proteínas do Tecido Nervoso/química , Proteínas do Tecido Nervoso/isolamento & purificação , Lobo Óptico de Animais não Mamíferos/metabolismo , Lobo Óptico de Animais não Mamíferos/ultraestrutura , Terminações Pré-Sinápticas/ultraestrutura , RNA Mensageiro/metabolismo , Proteínas de Ligação a RNA/química , Proteínas de Ligação a RNA/isolamento & purificação , Ribonucleoproteínas Citoplasmáticas Pequenas/genética , Ribonucleoproteínas Citoplasmáticas Pequenas/metabolismo , Sinaptossomos/metabolismo , Sinaptossomos/ultraestrutura
19.
Campinas; s.n; 2010. 215 p. ilus, graf, tab.
Tese em Português | LILACS | ID: lil-617598

RESUMO

MicroRNAs são moléculas recém-descobertas de RNA não-codificadores que possuem de 21 a 24 nucleotídeos e que regulam a expressão após a transcrição dos genes alvo. Essa regulação pode ser realizada através da inibição da tradução ou da degradação do RNA mensageiro. Os miRNAs estão envolvidos em vários processo biológicos como, diferenciação celular e desenvolvimento embrionário, além de apresentarem expressão tecido e tempo-específica. Eles podem regular a expressão de pelo menos 1/3 de todos os genes humanos e estão envolvidos com a regulação do metabolismo e da apoptose. Os miRNAs são a chave como reguladores pós-transcricionais da neurogênese; estudos mostram que eles possuem a expressão associada com a transição entre proliferação e diferenciação e também tem expressão constitutiva em neurônios maduros, evidenciando o envolvimento dessas moléculas com o desenvolvimento do sistema nervoso central (SNC). Outros miRNAs estão sendo estudados e verifica-se que eles agem como reguladores de genes envolvidos em doenças como Alzheimer, Parkinson e, provavelmente, também devam possuir um papel na regulação das epilepsias. No primeiro trabalho, apresentado no segundo capítulo, investigamos o papel dos miRNAs no desenvolvimento do SNC através da quantificação de 104 miRNAs em cérebros em desenvolvimento de camundongos. No segundo trabalho, apresentado no terceiro capítulo, para analisarmos o papel dos miRNAs na epilepsia de lobo temporal, verificamos se havia presença de miRNAs com expressão diferenciada entre tecidos removidos de pacientes que se submeteram a cirurgia de hipocampectomia e tecidos normais provenientes de autópsias. Para ambos os experimentos, foram extraídos os RNAs dos tecidos e quantificados por PCR em tempo real com o kit MicroRNA Assay baseado em iniciadores com estrutura em stem loop. Nos camundongos, análises de bioinformática encontraram quatro cluster de acordo com a expressão dos miRNAs...


MicroRNAs are a new class of small RNA molecules (21-24 nucleotide-long) that negatively regulate gene expression either by translational repression or target mRNA degradation. It is believed that about 30% of all human genes are targeted by these molecules. MiRNAs are involved in many important biological processes including cell differentiation, embryonic development and central nervous system formation, besides they showed specific temporal-space expression. They can regulate 1/3 of human genes and are involved in metabolism and apoptosis. miRNAs are the key as neurogenesis postranscriptional regulation; studies previous indicates miRNA expression associate with proliferation and differentiation in development of central nervous system (CNS) and housekeeping expression in mature neurons. They are involved in several diseases as Alzkeimer's and Parkinson and may have a role in epilepsy regulation. In second chapter, we analyze the miRNA expression in mouse brain during four stages of CNS development; in third chapter, we analyze hippocampal tissue of four patients who underwent selective resection of the mesial temporal structures for the treatment of clinically refractory seizures. In addition we used control samples from autopsy (n=4) for comparison. In both experiments, total RNA was isolated from tissues and used in real-time PCR reactions with TaqMan¿ microRNA assays (Applied Biosystems) to quantify 104 (mouse brain) or 157 (human tissue) different miRNAs...


Assuntos
Humanos , Animais , Masculino , Feminino , Camundongos , Epilepsia do Lobo Temporal , Epilepsia do Lobo Temporal/genética , MicroRNAs , MicroRNAs/fisiologia , MicroRNAs/ultraestrutura , Apoptose , Epilepsia do Lobo Temporal/fisiopatologia , MicroRNAs/genética , Sistema Nervoso Central/ultraestrutura
20.
Int. j. morphol ; 27(3): 879-889, sept. 2009. ilus
Artigo em Inglês | LILACS | ID: lil-598952

RESUMO

The aim of this work was to determine the chronical stress effects on the encephalic NPY neurons population during the fetal Central nervous system development. Immunocytochemical techniques were used for this purpose: NPY neurons presented a similar morphology during the gestation days studied but their distribution varied in the anterior, medium and posterior brain. Statistical Highly significant differences in number of NPY positive neurons (p<0.01) among anterior, medium and posterior brain of stressed fetus (SF) were determined depending on the gestation period and the brain area. The NPY neurons were increased in ARC (Arcuate Hypothalamic Nucleus), PH (Posterior Hypothalamic Area) and DM (Dorsomedial Hypothalamic Nucleus) in stressed fetuses (SF) of 17 days, and in ARC of 19 days SF (p< 0.01) were detected in the different brain nucleus. The NPY population increased in PnO (Pontine Reticular Nu, Oral Part) and RITg (Reticulotegmental Nu of the Pons) of 17 days SF, while they were detected in posterior brain at Pyx (Pyramidal Decussation), Rob (Raphe Obscurus Nucleus) and RPA (Raphe Pallidus Nucleus) in SF of 19 days. They also increased in number (p<0.05) in DPGI (Dorsal Paragigantocellular Nu), CGPn (Central Gray of Pons) and PrH (Prepositus Hypoglossal Nucleus) of 17 days SF. Finally, any statistical differences were found among CF and SF in the following nuclei: anterior brain, AH (Anterior Hypothalamic Nucleus), DM (Dorsomedia L Hypothalamic Nucleus) of 17 days; ME (Median Eminence)., VMH (Ventromedial Hypothalamic Nucleus) of 19 days; medium brain in CG (Central Periaqueductal Gray), DR (Dorsal Raphe Nucleus) of 17 days and posterior brain in PnC (Pontine Reticular Nu, Caudal Part), PrH (Prepositus Hypoglossal Nucleus), RMgG (Raphe Magnus Nucleus), IO (Inferior Olive) of 17 days. The increase number of NPY neurons found in the stressed rat fetuses in all periods studied would indicate the participation of the NPY System in...


El propósito del presente estudio fue determinar los efectos del estrés crónico en la población de neuronas NPY encefálicas durante el desarrollo del S.N.C. fetal mediante técnicas inmunocitoquímicas. Se demostró que las neuronas NPY presentan un morfología similar en los días de gestación estudiados, pero su distribución varía en el cerebro anterior, medio y posterior. Se comprobaron diferencias altamente significativas entre el cerebro anterior, medio y posterior (p<0,01) de fetos estresados (FE), variando dicha significación dependiendo del día de la gestación y del área estudiada. En los diferentes núcleos cerebrales del cerebro anterior se detectaron aumentos en ARC (Arcuate Hypothalamic Nucleus), PH (Posterior Hypothalamic Area) de 17 días y DM (Dorsomedia L Hypothalamic Nucleus) y en ARC (Arcuate Hypothalamic Nucleus) de 19días (p<0,01) de F.E. En el cerebro medio se detectaron aumentos en DR (Dorsal Raphe Nucleus) (p<0,01) y PN (Pontine Nucleus) (p<0,05) de 19 F.E. En el cerebro posterior se detectaron aumentos en PnO (Pontine Reticular Nu, Oral Part) y RITg (Reticulotegmental Nu of the Pons) de 17 F. E. y Pyx, (Pyramidal Decussation), Rob (Raphe Obscurus Nucleus) y RPA (Raphe Pallidus Nucleus) de 19 F.E. Asimismo se comprobaron aumentos (p<0,05) en DPGI (Dorsal Paragigantocellular Nu.) de 17 F.E, CGPn (Central Gray of Pons) y PrH (Prepositus Hypoglossal Nucleus), de 19 F.E. Finalmente, no se comprobaron diferencias entre F. C. (fetos controles) y F. E. en los siguientes núcleos del cerebro anterior: AH (Anterior Hypothalamic Nucleus), DM (Dorsomedia L Hypothalamic Nucleus), de 17 días; y EM, (Median Eminence), VMH (Ventromedial Hypothalamic Nucleus) de 19 días. En el cerebro medio CG, (Central Periaqueductal Gray), DR (Dorsal Raphe Nucleus) de 17 días. En el cerebro posterior el PnC, (Pontine Reticular Nu, Caudal Part), PrH (Prepositus Hypoglossal Nucleus), RMgG (Raphe Magnus Nucleus), IO (Inferior Olive) de 17 días del cerebro posterior...


Assuntos
Animais , Feminino , Gravidez , Recém-Nascido , Lactente , Camundongos , Neurônios/citologia , Neurônios , Neurônios/fisiologia , Neurônios/química , Neurônios/ultraestrutura , Estresse Fisiológico , Exposição Materna , Ratos Wistar/anatomia & histologia , Ratos Wistar/embriologia , Sistema Nervoso Central/anatomia & histologia , Sistema Nervoso Central/embriologia , Sistema Nervoso Central/ultraestrutura
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA